- Fund vehicles
- 4
- Launches
- 4
- Form D filings
- 13
- First seen
- 2024-12-17
- Latest filing
- 2026-04-02
- Based in
- New York
Blackstone Life Sciences: Form D filings
Every fund vehicle filed under the Blackstone Life Sciences name since 2024: original launches and D/A raise updates, with offering size, stage, strategy and the people on each filing. Sponsor identity is inferred from the entity name; verify on the filing.
13 filings in the last 730 days · page 1 of 1
| Score | Filed | Issuer | Type | Stage | Offering | Sold | Location | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|
| 47 | 2026-04-02 | Blackstone Life Sciences VI L.P. | Private equity / buyout | Closed | $6.3B | $6.3B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 47 | 2026-04-02 | Blackstone Life Sciences VI - B L.P. | Private equity / buyout | Closed | $6.3B | $6.3B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 47 | 2026-04-02 | Blackstone Life Sciences VI (LUX) SCSp | Private equity / buyout | Closed | $6.3B | $6.3B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 47 | 2026-04-02 | Blackstone Life Sciences VI - BL L.P. | Private equity / buyout | Closed | $6.3B | $6.3B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 37 | 2025-12-09 | Blackstone Life Sciences VI (LUX) SCSp | Private equity / buyout | Open-ended | Indefinite | $3.62B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 37 | 2025-12-09 | Blackstone Life Sciences VI L.P. | Private equity / buyout | Open-ended | Indefinite | $3.62B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 72 | 2025-11-20 | Blackstone Life Sciences VI - B L.P. | Private equity / buyout | Open-ended | Indefinite | $3.62B | NEW YORK, NY | 3(c)(7) — qualified purchasersFirst filing by this entityrepeat_fund_numeral | EDGAR |
| 72 | 2025-11-20 | Blackstone Life Sciences VI - BL L.P. | Private equity / buyout | Open-ended | Indefinite | $3.62B | NEW YORK, NY | 3(c)(7) — qualified purchasersFirst filing by this entityrepeat_fund_numeral | EDGAR |
| 37 | 2025-10-08 | Blackstone Life Sciences VI L.P. | Private equity / buyout | Open-ended | Indefinite | $3.29B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 37 | 2025-10-08 | Blackstone Life Sciences VI (LUX) SCSp | Private equity / buyout | Open-ended | Indefinite | $3.29B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 37 | 2025-04-23 | Blackstone Life Sciences VI L.P. | Private equity / buyout | Open-ended | Indefinite | $1.79B | NEW YORK, NY | 3(c)(7) — qualified purchasers | EDGAR |
| 82 | 2024-12-17 | Blackstone Life Sciences VI L.P. | Private equity / buyout | Pre-first close | Indefinite | — | NEW YORK, NY | 3(c)(7) — qualified purchasersPre-first closeFirst filing by this entity+2 | EDGAR |
| 82 | 2024-12-17 | Blackstone Life Sciences VI (LUX) SCSp | Private equity / buyout | Pre-first close | Indefinite | — | NEW YORK, NY | 3(c)(7) — qualified purchasersPre-first closeFirst filing by this entity+1 | EDGAR |
Free weekly sample: five scored private-fund launches every Monday
One week delayed, headline and summary only, no card. It exists so you can judge the scoring before paying.